{"id":16255,"date":"2020-06-16T12:14:58","date_gmt":"2020-06-16T16:14:58","guid":{"rendered":"https:\/\/medicarereport.org\/?p=16255"},"modified":"2020-06-16T12:14:58","modified_gmt":"2020-06-16T16:14:58","slug":"early-results-show-benefit-of-steroid-for-very-sick-covid-19-patients","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=16255","title":{"rendered":"Early Results Show Benefit Of Steroid For Very Sick COVID-19 Patients"},"content":{"rendered":"<p>(By Joe Palca for NPR)<\/p>\n<p>A low-cost anti-inflammatory drug appears to reduce the risk of death in patients with COVID-19.<\/p>\n<p>The drug is called dexamethasone. It&#8217;s been used for decades to treat conditions such as arthritis and asthma. Because patients with advanced COVID-19 disease can have severe lung inflammation, scientists wanted to see if dexamethasone could treat that.\u00a0 Continue reading article <a href=\"https:\/\/www.npr.org\/sections\/coronavirus-live-updates\/2020\/06\/16\/878069587\/early-results-show-benefit-of-steroid-for-very-sick-covid-19-patients\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3902\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" width=\"152\" height=\"55\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 152px) 100vw, 152px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Joe Palca for NPR) A low-cost anti-inflammatory drug appears to reduce the risk of death in patients with COVID-19.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,15],"tags":[],"class_list":["post-16255","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16255"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16255\/revisions"}],"predecessor-version":[{"id":16256,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16255\/revisions\/16256"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}